Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT).
https://mma.prnewswire.com/media/2395212/Glancy_Prongay.jpg
IF YOU SUFFERED A LOSS ON YOUR APPLIED THERAPEUTICS INVESTMENTS, CLICK HEREBEFORE FEBRUARY 18, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT
What Is The Lawsuit About? The complaint filed alleges that, between January 3, 2024 and December 2, 2024, Defendants failed to disclose to investors that: (1) Applied Therapeutics was not adhering to trial protocol and good clinical practices which, in turn, created an exceedingly severe risk that the trial data would be rejected by the FDA in the context of an NDA; and (2) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Contact Us To Participate or Learn More:
If you wish tolearn moreabout this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.CharlesLinehan, Esq.,Glancy Prongay & Murray LLP,1925 Century Park East, Suite 2100, Los Angeles California 90067 Email: shareholders@glancylaw.comTelephone: 310-201-9150 (Toll-Free: 888-773-9224) Visit our website atwww.glancylaw.com.Follow us for updates on LinkedIn, Twitter, or Facebook.
If you inquire by email, please include your mailing address, telephone number and number of shares purchased.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact Us:Glancy Prongay & Murray LLP, 1925 Century Park East, Suite 2100,Los Angeles, CA 90067Charles LinehanEmail: shareholders@glancylaw.comTelephone: 310-201-9150Toll-Free: 888-773-9224 Visit our website at:www.glancylaw.com.
https://c212.net/c/img/favicon.png?sn=LA07923&sd=2025-01-30
View original content to download multimedia:https://www.prnewswire.com/news-releases/applied-therapeutics-inc-aplt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-302364124.html
SOURCE Glancy Prongay & Murray LLP
https://rt.newswire.ca/rt.gif?NewsItemId=LA07923&Transmission_Id=202501301200PR_NEWS_USPR_____LA07923&DateId=20250130